AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036

12/06/2025 – AB Science today announced that the patent office of Canada has  granted a patent protecting the composition of matter of AB8939, and closely related compounds, until 2036